|Articles|March 1, 2011
- Pharmaceutical Executive-03-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - March 2011
Castellani Takes Charge at PhRMA
Advertisement
Articles in this issue
over 14 years ago
PICASSO—Truly a Work of Artover 14 years ago
The Netherlands: Innovation through Collaborationover 14 years ago
Restructured for Successover 14 years ago
The "Other" Innovationover 14 years ago
Where have all the Scientists Gone?over 14 years ago
Making Sense of Market Chaosover 14 years ago
Pharm Exec's Seventh Annual Media Auditover 14 years ago
New Tools Track Safety, Value in Medicineover 14 years ago
A Rule of Thumb Gets Shot Downover 14 years ago
John Castellani: Industry's Level Bet on a Dizzying FutureNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Targeting CCR5 Receptors
2
Komzifti Gains FDA Approval, Giving Kura Oncology and Kyowa Kirin a Key Strategic Win in NPM1-Mutated AML
3
Merck to Acquire Cidara for $9.2 Billion
4
DEI Changes in Pharma: A Look Back at 2025 & Predictions for 2026
5
